Compositions and formulations for producing analgesia and for inhibiting progression of neuropathic pain disorders
CA 2224795 C · Owner: Luther, Robert R. · Inventors: Adriaenssens, Peter Isadore; Gohil, Kishorchandra; Luther, Robert R.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Disclosed are omega-conopeptide containing medicaments for inhibiting progression of neuropathic pain disorders. The invention also includes an omega-conopeptide formulation that prevents oxidation of the peptide as well , as novel omega-conopeptides SNX-273 and SNX-279. In a related aspect the , invention includes an improved method of epidural administration of omega conopeptides.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 26, 1996 and granted April 3, 2001. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 26, 2016.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 26, 2018.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.